1 in 3 US Clinics Now Owned by Private Equity Firms

By VirentaNews Staff — May 14, 2026

One in three medical clinics in the United States is now owned or partially controlled by private equity firms — a seismic shift in healthcare delivery that has gone largely unnoticed by the public. Since 2010, private equity investment in healthcare has ballooned from $11 billion to over $120 billion annually, according to data from PitchBook. Behind this surge lies a troubling pattern: clinics acquired by investment firms often see rapid cost-cutting, staff reductions, and pressure to maximize billing — all while patient satisfaction and clinical outcomes decline. A 2023 study published in JAMA Internal Medicine found that patients receiving care at private equity-owned practices reported significantly lower satisfaction rates and higher rates of unmet medical needs compared to those in physician-led clinics. This quiet takeover of frontline healthcare is transforming the patient experience — not for the better.

The Rise of Financial Medicine

For decades, medical practices were predominantly owned and operated by physicians, with decisions guided by clinical expertise and patient welfare. That model is eroding. Fueled by low interest rates, abundant capital, and the promise of steady healthcare revenues, private equity firms have increasingly targeted outpatient care as a lucrative asset class. The logic is simple: healthcare demand is inelastic — people will pay for medical services — and clinics generate predictable cash flows. But the financial engineering behind these acquisitions often prioritizes short-term returns over long-term care quality. By loading clinics with debt, cutting administrative and clinical staff, and demanding higher patient volumes, private equity firms extract value — sometimes at the expense of care. This shift marks a fundamental change in the ethos of medicine: from stewardship to yield optimization.

How Equity Firms Took Over Primary Care

The acquisition strategy typically follows a familiar playbook. A private equity firm, often through a portfolio company like OrthoAlliance or Dental Support Organization (DSO) networks, buys multiple small practices and consolidates them under a single corporate umbrella. These roll-up models promise operational efficiency and better access to technology and marketing. In reality, the focus shifts to maximizing revenue per square foot and per provider. Dentists, for example, report being pressured to upsell cosmetic treatments, while primary care physicians in equity-owned clinics face quotas on patient visits and referrals to in-house labs. Veterinarians aren’t immune — the BBC reported in 2023 that major veterinary chains backed by private equity had raised prices by over 40% in two years while reducing appointment times. Employees across specialties describe high turnover, burnout, and ethical dilemmas as clinical judgment is secondary to profit targets.

Profit Over Patients: The Data Behind the Decline

Mounting evidence suggests private equity ownership correlates with worse outcomes. A 2022 investigation by Reuters analyzed over 200 equity-owned clinics and found that 60% had been cited for regulatory violations or malpractice within five years of acquisition — double the rate of independent practices. Another study in Health Affairs showed that private equity-backed dental chains charged 23% more for common procedures than independent dentists, with no measurable improvement in outcomes. The financial structure itself creates pressure: clinics are often required to service acquisition debt, leaving less funding for training, equipment, or staff retention. One former executive at a PE-owned dermatology chain described the model bluntly: ‘We weren’t running a medical business — we were running a financial asset with doctors attached.’

Who Bears the Cost of Financialized Care?

The consequences ripple across the healthcare system. Patients face higher out-of-pocket costs, rushed appointments, and fragmented care as clinicians turnover. Frontline providers — nurses, hygienists, and physicians — report deteriorating work environments and moral injury. Independent practitioners struggle to compete with well-funded chains that can dominate local markets through aggressive marketing and acquisition. Meanwhile, insurers and public programs like Medicare may absorb hidden costs when complications arise from substandard care. Rural and underserved communities are especially vulnerable, as private equity firms often target stable, profitable clinics in affluent areas, accelerating the hollowing out of local medical ecosystems. The commodification of care risks turning medicine into a transactional service rather than a relational practice — with long-term implications for trust and public health.

Expert Perspectives

Health economists are divided on whether regulation can curb the trend. Dr. David Himmelstein of City University of New York argues that ‘private equity’s entry into medicine represents a predatory financialization that undermines the doctor-patient relationship.’ In contrast, some business analysts defend consolidation as inevitable in a high-cost system, with McKinsey noting that ‘scale brings efficiency’ if managed ethically. Yet even proponents acknowledge the lack of transparency: most private equity firms are not required to disclose performance metrics or patient outcomes. Without oversight, the incentive structure remains skewed toward extraction rather than care improvement.

What comes next may depend on policy. The U.S. Senate Finance Committee has launched inquiries into private equity’s role in healthcare, and some states are considering ‘private equity in healthcare’ disclosure laws. Investors, too, may face pressure as ESG scrutiny grows. But with trillions in dry powder waiting to be deployed, the financial appetite for medical assets shows no sign of slowing. The central question remains: can healthcare serve both patients and shareholders — or is the current model sacrificing one for the other?

Source: Thefirmo